Literature DB >> 23568547

miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2.

Tao Song1, Xu Zhang, Lei Zhang, Jun Dong, Wei Cai, Jiangping Gao, Baofa Hong.   

Abstract

PURPOSE: Bladder cancer is one of the world's top ten malignant tumors. The crucial role of microRNA in carcinogenesis has been well emphasized. Considering miRNA expression was tumor stage-, tissue-, or even development-specific, more experimental evidences about the functions of miRNAs in bladder cancer should be discovered to advance applying of miRNA in the diagnosis or therapy of cancer.
METHODS: MiR-708 level in bladder carcinoma and adjacent noncancerous tissues was tested by real-time qPCR. Cell apoptosis was analyzed by using flow cytometry. The tumorigenicity of bladder carcinoma cells was evaluated in nude mice model. Luciferase reporter gene assays were performed to identify the interaction between miR-708 and 3'UTR of Caspase-2 mRNA. The protein level of Caspase-2 was determined by western blotting.
RESULTS: In this study, we reported that miR-708 was frequently dysregulated in human bladder carcinoma tissues compared to normal tissues. In addition, we found that silencing of miR-708 could promote the T24 and 5637 cells to apoptosis and inhibit the bladder tumor growth in vivo. Also, Caspase-2 was proved to be one of direct targets of miR-708 in T24 and 5637 cells. Further results showed that Caspase-2 was involved in the miR-708 regulated cell apoptosis.
CONCLUSIONS: All together, these results suggest miR-708 may act as an oncogene and induce the carcinogenicity of bladder cancer by down-regulating Caspase-2 level.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23568547     DOI: 10.1007/s00432-013-1392-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  39 in total

Review 1.  Caspases: enemies within.

Authors:  N A Thornberry; Y Lazebnik
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

2.  Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.

Authors:  Keqin Ren; Jing Lu; Aleksey Porollo; Chunying Du
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 3.  Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients.

Authors:  H W Herr
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 4.  MicroRNAs: small but potent oncogenes or tumor suppressors.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Curr Opin Investig Drugs       Date:  2006-06

5.  Differential miRNA expression profiles in bladder urothelial carcinomas.

Authors:  Tao Song; Wei Xia; Ningsheng Shao; Xu Zhang; Chunyang Wang; Yiguang Wu; Jun Dong; Wei Cai; Hongzhao Li
Journal:  Asian Pac J Cancer Prev       Date:  2010

6.  Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing.

Authors:  Yu-Hua Chen; Si-Qi Wang; Xiu-Ling Wu; Mo Shen; Zhan-Guo Chen; Xiao-Gang Chen; Yong-Xia Liu; Xiao-Li Zhu; Fei Guo; Xiu-Zhi Duan; Xiu-Cui Han; Zhi-Hua Tao
Journal:  Urol Oncol       Date:  2011-07-27       Impact factor: 3.498

7.  Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway.

Authors:  Clay C C Wang; Yi-Ming Chiang; Po-Lin Kuo; Jiunn-Kae Chang; Ya-Ling Hsu
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07-29       Impact factor: 2.557

Review 8.  Caspase-2: controversial killer or checkpoint controller?

Authors:  Tanja Kitevska; Damian M S Spencer; Christine J Hawkins
Journal:  Apoptosis       Date:  2009-07       Impact factor: 4.677

9.  Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers.

Authors:  Jin Sung Jang; Hyo-Sung Jeon; Zhifu Sun; Marie Christine Aubry; Hui Tang; Cheol-Hong Park; Fariborz Rakhshan; Debra A Schultz; Christopher P Kolbert; Ruth Lupu; Jae Yong Park; Curtis C Harris; Ping Yang; Jin Jen
Journal:  Clin Cancer Res       Date:  2012-05-09       Impact factor: 12.531

10.  A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.

Authors:  Bo-Wei Han; Dan-Dan Feng; Zhi-Gang Li; Xue-Qun Luo; Hua Zhang; Xiao-Juan Li; Xing-Ju Zhang; Ling-Ling Zheng; Cheng-Wu Zeng; Kang-Yu Lin; Peng Zhang; Ling Xu; Yue-Qin Chen
Journal:  Hum Mol Genet       Date:  2011-09-17       Impact factor: 6.150

View more
  31 in total

1.  Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.

Authors:  Rosário Pinto-Leite; Isabel Carreira; Joana Melo; Susana Isabel Ferreira; Ilda Ribeiro; Jaqueline Ferreira; Marco Filipe; Carina Bernardo; Regina Arantes-Rodrigues; Paula Oliveira; Lúcio Santos
Journal:  Tumour Biol       Date:  2014-01-24

2.  miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3.

Authors:  Qi Li; Sheng Li; Yaolu Wu; Feng Gao
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

Review 3.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

4.  miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1.

Authors:  Alan P Lombard; Benjamin A Mooso; Stephen J Libertini; Rebecca M Lim; Rachel M Nakagawa; Kathleen D Vidallo; Nicole C Costanzo; Paramita M Ghosh; Maria Mudryj
Journal:  Mol Carcinog       Date:  2015-04-11       Impact factor: 4.784

5.  miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.

Authors:  Sinan Sun; Tianyi Hang; Boyu Zhang; Liang Zhu; Yang Wu; Xiangwei Lv; Qiang Huang; Hanhui Yao
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

6.  MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.

Authors:  Yue Wang; Ming Cui; Bao-di Sun; Fa-bao Liu; Xiao-dong Zhang; Li-hong Ye
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

7.  Tumor Protein p63/microRNA Network in Epithelial Cancer Cells.

Authors:  Edward A Ratovitski
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

Review 8.  MicroRNAs: novel players in cancer diagnosis and therapies.

Authors:  Aaron L Oom; Brock A Humphries; Chengfeng Yang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

9.  Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells.

Authors:  San-Lin Lei; Hua Zhao; Hong-Liang Yao; Yong Chen; Zhen-Dong Lei; Kui-Jie Liu; Qun Yang
Journal:  Oncol Lett       Date:  2014-07-09       Impact factor: 2.967

10.  miR-708/LSD1 axis regulates the proliferation and invasion of breast cancer cells.

Authors:  Lin Ma; Shan Ma; Guimei Zhao; Longqiu Yang; Peng Zhang; Qingting Yi; Shuguang Cheng
Journal:  Cancer Med       Date:  2016-02-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.